Consumer products company Colgate-Palmolive (NYSE:CL) will be reporting earnings tomorrow morning. Here's what to expect.
Last quarter Colgate-Palmolive reported revenues of $4.92 billion, up 10.3% year on year, beating analyst revenue expectations by 2.1%. It was a strong quarter for the company, with a decent beat of analysts' revenue estimates.
Is Colgate-Palmolive buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting Colgate-Palmolive's revenue to grow 5.5% year on year to $4.88 billion, in line with the 5.1% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.85 per share.
The analysts covering the company have been growing increasingly bullish about the business heading into the earnings, with revenue estimates seeing four upwards revisions over the last thirty days. The company missed Wall St's revenue estimates twice over the last two years.
Looking at Colgate-Palmolive's peers in the household products segment, some of them have already reported Q4 earnings results, giving us a hint what we can expect. WD-40 delivered top-line growth of 12.4% year on year, beating analyst estimates by 4.5% and Kimberly-Clark (NYSE:KMB) reported revenues up 0.1% year on year, missing analyst estimates by 0.5%. WD-40 traded up 5.6% on the results, and Kimberly-Clark was down 1.8% on the results.
Read the full analysis of WD-40's and Kimberly-Clark's results on StockStory.
There has been a stampede out of high valuation technology stocks and while some of the household products stocks have fared somewhat better, they have not been spared, with share price declining 3.1% over the last month. Colgate-Palmolive is up 1.2% during the same time, and is heading into the earnings with analyst price target of $86, compared to share price of $80.08.
The author has no position in any of the stocks mentioned.